Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- EGHT +8.4%, INTC +6.1%, DWCH +4.9%, MXIM +4.5%, AVYA +3.3%, ABBV +1.8%, LEA +1.2%, MATW +1.1%, FLEX +1%, COL +0.6%, MSTR +0.5%, FHB +0.5%
M&A news:
- GST +13.6% (to divest interest in West Edmund Hunton Lime Unit for $107.5 million; expected to close on or before February 28, 2018)
- VMW +7.2% (Dell (DVMT) considering IPO or purchase of rest of VMW, according to WSJ )
- AVXS +1.2% (Citigroup called it an interesting take out candidate)
Other news:
- NVIV +12.8% (enters a common stock purchase agreement with Lincoln Park Capital Fund to sell up to $15 million in shares of common stock)
- MYO +9.5% (continued strength)
- EDIT +3% (Adverum Biotech and Editas Medicine announce extension to the cos' collaboration agreement through 3Q18)
- ADVM +1.6% (Adverum Biotech and Editas Medicine announce extension to the cos' collaboration agreement through 3Q18)
- NKE +1.4% (higher on reports that Pershing's Bill Ackman discussed investment at client dinner)
- NWL +1.4% (modestly rebounding from today's 21% decline)
- AZN +1.4% (reports top-line Phase III KRONOS trial results; demonstrates significant improvement in eight out of nine lung function primary endpoints)
- TSLA +1.3% (spokesperson has denied issues with Model 3 production)
Analyst comments:
- ATOS +10.8% (initiated with a Buy at Maxim Group; tgt $2 (stock closed at 0.32 on Thurs))
- EXPO +2.2% (upgraded to Buy from Hold at SunTrust)
- GILD +0.9% (upgraded to Buy from Hold at Jefferies)